9 employees
PureIMS provides dry powder inhalation, compounding clinical trial medication, compounding pharmacy, and pulmonary administration services.
2014
PureIMS raised undisclosed on April 3, 2023
Investors: Carduso Capital B.V and Balsz Elementary School